Annual Report 2020

FINANCIAL HIGHLIGHTS 5 The United Laboratories International Holdings Limited Annual Report 2020 2020 2019 Increase (decrease) RMB’000 RMB’000 % Revenue 8,772,488 8,392,600 4.5% EBITDA 1,678,072 1,798,222 (6.7%) Profit before taxation 882,334 841,652 4.8% Profit for the year attributable to owners of the Company 702,989 641,764 9.5% Earnings per share Basic RMB39.81cents RMB39.14 cents 1.7% Diluted RMB39.81cents RMB39.14 cents 1.7% 641.8 (272.4) 81.8 682.9 2016 2017 2016 2017 1,125.5 2018 1,788.4 813.4 2019 1,798.2 2016 2017 2018 5.0 2016 2017 41.8 2018 (16.7) 39.1 2019 39.8 2020 2018 0 100 200 300 -300 -200 -100 400 500 600 700 800 50 40 30 20 10 0 -10 -20 2019 2020 1,678.1 2020 2,000 1,500 1,000 500 0 10,000 8,000 6,000 4,000 2,000 0 2019 2020 1,473.5 2,853.4 2,499.7 1,233.6 3,389.7 2,887.3 1,235.1 6,077.9 6,826.6 7,510.6 8,392.6 2,470.5 2,372.3 1,280.4 3,593.1 3,519.1 8,772.5 1,429.7 3,620.7 3,722.1 703.0 REVENUE (RMB million) BASIC EARNINGS (LOSS) PER SHARE (RMB cents) PROFIT (LOSS) FORTHEYEAR ATTRIBUTABLE TO OWNERS OFTHE COMPANY (RMB million) EBITDA (RMB million) Intermediate products Bulk medicine Finished products